IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

218 hedge funds and large institutions have $1.44B invested in Iovance Biotherapeutics in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 90 increasing their positions, 65 reducing their positions, and 39 closing their positions.

Holders
218
Holders Change
-9
Holders Change %
-3.96%
% of All Funds
3.44%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
31
Increased
90
Reduced
65
Closed
39
Calls
$10.9M
Puts
$5.88M
Net Calls
+$5M
Net Calls Change
+$4.32M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$144M
2
BlackRock
2
BlackRock
New York
$120M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$36.4M
4
Deutsche Bank
4
Deutsche Bank
Germany
$23.3M
5
HRCM
5
Hood River Capital Management
Florida
$13.9M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$24.6M
2
Franklin Resources
2
Franklin Resources
California
$129K
3
Citadel Advisors
3
Citadel Advisors
Florida
$9.39M
4
DM
4
Deerfield Management
New York
$0
5
KCM
5
Kynam Capital Management
New Jersey
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$144M 20,395,388 +6,855,259 +51%
BlackRock
2
BlackRock
New York
$120M 17,001,791 +4,545,129 +36%
PA
3
Perceptive Advisors
New York
$98.8M 14,036,410 -1,303,325 -8%
State Street
4
State Street
Massachusetts
$95.5M 13,565,798 -167,235 -1%
MFM
5
MHR Fund Management
New York
$84.5M 11,997,103 – –
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$54.8M 7,786,985 -1,013,074 -12%
ACA
7
Avoro Capital Advisors
New York
$47.2M 6,700,000 -320,000 -5%
PAMS
8
Pictet Asset Management (Switzerland)
Switzerland
$36.4M 5,175,080 +4,210,788 +437%
O
9
OrbiMed
New York
$33.1M 4,707,458 – –
Artisan Partners
10
Artisan Partners
Wisconsin
$31.2M 4,426,741 +858,035 +24%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$29.1M 4,138,362 +1,098,929 +36%
BC
12
Boxer Capital
California
$26.1M 3,705,133 – –
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$25.8M 3,663,373 -92,495 -2%
Millennium Management
14
Millennium Management
New York
$25.2M 3,580,668 +168,069 +5%
Goldman Sachs
15
Goldman Sachs
New York
$24.9M 3,535,267 -397,717 -10%
Morgan Stanley
16
Morgan Stanley
New York
$24.6M 3,497,608 -4,195,083 -55%
Deutsche Bank
17
Deutsche Bank
Germany
$23.3M 3,311,980 +2,387,330 +258%
MB
18
MPM BioImpact
Massachusetts
$20.8M 2,950,118 +335,141 +13%
CS
19
Credit Suisse
Switzerland
$19.7M 2,794,124 +97,282 +4%
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$18.6M 2,635,287 +565,916 +27%
Sumitomo Mitsui Trust Group
21
Sumitomo Mitsui Trust Group
Japan
$17.5M 2,490,600 -82,491 -3%
NAMA
22
Nikko Asset Management Americas
New York
$17.5M 2,490,600 -58,391 -2%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$15.7M 2,229,281 +73,739 +3%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$14.8M 2,097,003 +587,770 +39%
HRCM
25
Hood River Capital Management
Florida
$13.9M 1,975,551 +1,975,551 New
1
2 3 4 5